Stockscreener 앱 받기
7.88
5.40%
-0.45
Biodesix Inc 주식(BDSX)의 최신 뉴스
Biodesix Inc. (BDSX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - Sahm
BDSX Stock Price, Forecast & Analysis | BIODESIX INC (NASDAQ:BDSX) - Chartmill
Biodesix stock soars as preliminary results exceed guidance, achieves EBITDA profitability - Investing.com Nigeria
Quarterly Trades: Will Biodesix Inc stock rally after Fed decisions2025 Market Overview & Growth Focused Entry Point Reports - Bộ Nội Vụ
Biodesix: Strengthening Fundamentals, Emerging Profitability, and Strategic Growth Support Buy Rating and $20 Price Target - TipRanks
Biodesix: Strong Operational Momentum but Ongoing Capital Concerns Justify Hold Rating - TipRanks
Biodesix reports 41% revenue growth in Q4, exceeds 2025 guidance By Investing.com - Investing.com Nigeria
Biodesix sees stock soar after surpassing sales guidance - BizWest
BDSX Faces Financial Hurdles as Stock Volatility Heightens - StocksToTrade
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability - FinancialContent
BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? - Asianet Newsable
Biodesix Stock Rebounds on Strategic Plans for Market Expansion - timothysykes.com
This Diagnostics Stock Is Surging 23% Pre-Market Today – Here’s Why - Stocktwits
Biodesix (BDSX) Surges 41% on Strong Preliminary Q4 and FY Resul - GuruFocus
Biodesix Surges On Strong Preliminary Q4 And FY2025 Revenue Results - Nasdaq
Biodesix skyrockets 43%, expects FY revenue to beat guidance - MSN
Biodesix (BDSX) Surpasses 2025 Revenue Expectations with Strong Q4 Performance - GuruFocus
Biodesix reports 41% revenue growth in Q4, exceeds 2025 guidance - Investing.com
Biodesix, Inc. Reports Estimated Q4 2025 Revenue of $28.8 Million, Achieving 41% Growth and Full-Year Revenue of $88.5 Million, Up 24% - Quiver Quantitative
Biodesix prelim Q4 revenue beats expectations, helped by growth in Lung Diagnostics - TradingView — Track All Markets
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited) - Bluefield Daily Telegraph
Biodesix, Inc. Provides Earnings Guidance for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 325.67%: Here's is How to Trade - MSN
Is Biodesix Inc. stock affected by interest rate hikesWeekly Investment Summary & Daily Chart Pattern Signals - Улправда
What dividend safety score for Biodesix Inc. stockDurability and Wear Notes & HOKA model picks for your routine - ulpravda.ru
Will Biodesix Inc. stock split again soonTreasury Yields & Capital Efficiency Focused Ideas - Улправда
How geopolitical tensions affect Biodesix Inc. stock2025 Momentum Check & Fast Gaining Stock Reports - Улправда
Will Biodesix Inc. stock benefit from automationMarket Risk Report & Fast Exit/Entry Strategy Plans - Улправда
BDSX stock touches 52-week low at $1 amid market challenges - MSN
Fundamentals Check: Why analysts recommend Modine Manufacturing Company MMF stockJuly 2025 Market Mood & Free Real-Time Market Sentiment Alerts - moha.gov.vn
Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut - MSN
Biodesix CFO sells $22,794 in stock - MSN
BDSX Stock Rises After Publication of Study Data for Nodify CDT Test - MSN
Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth - MSN
Options Flow: What dividend safety score for Biodesix Inc stock2025 Top Decliners & Low Risk High Win Rate Picks - moha.gov.vn
Analyst Calls: Why analysts upgrade Biodesix Inc stock2025 Price Action Summary & Growth Focused Entry Reports - moha.gov.vn
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN
Is Biodesix Inc. stock attractive for retirement portfoliosGap Down & Safe Capital Growth Stock Tips - Улправда
Why Biodesix Inc. stock is considered a top pick2025 Valuation Update & Precise Trade Entry Recommendations - DonanımHaber
Price Action: Can Biodesix Inc. stock continue upward trendEarnings Recap Summary & AI Enhanced Trading Signals - Улправда
Why retail investors favor Biodesix Inc. stockTrade Performance Summary & Step-by-Step Swing Trade Plans - DonanımHaber
Will Biodesix Inc. stock attract ESG investors2025 Major Catalysts & Fast Moving Trade Plans - DonanımHaber
2.51%
0.74%
자본화:
|
볼륨(24시간):